Changes of PTH, 1,25(OH)2D3 and Biochemistry in Renal Osteodystrophy.

被引:0
|
作者
Jia Jing-kang
33(1):33.
机构
关键词
Changes of PTH; OH; and Biochemistry in Renal Osteodystrophy; HTO; LTO;
D O I
暂无
中图分类号
R681 [骨骼疾病];
学科分类号
1002 ; 100210 ;
摘要
The changes of plasma PTH, 1,25(OH)D, serum calcium, phosphorus and AKP were observed in 55 uremic patients with renal osteodystrophy. The results showed that: in all types of renal osteodystrophy, plasma PTH were markedly higher than normal (P<0.001), while plasma 1,25(OHH)Dand serum calcium were lower than normal (P<0.001). In low bone-turnover uremic osteodystrophy (LTO), plasma phosphorus was markedly lower than that of high bone-turnover uremic osteodystrophy (HTO) and mixe d uremic osteodystrophy (MO) (P<0.05), and plasma 1,25(OH)Dwas significantly lower than that of HTO (P<0.05). In HTO and MO, serum phosphorus was much higher than mormal (P<0.001). Plasma PTH had a negative linear correlation with plasma 1,25(OH)D(P<0.05), a positive linear correlation with serum AKP (P<0.05), but no linear correlation with the duration of hemodialysis, serum calcium, serum aluminum and bone aluminum content. Plasma 1.25(OH)Dhad no linear correlation with the duration of hemodialysis, seru
引用
收藏
页码:21 / 21
页数:1
相关论文
共 50 条
  • [21] EFFECT OF PTH AND 1,25(OH)2D3 ON RENAL 25(OH)D3 METABOLISM, ADENYLATE-CYCLASE, AND PROTEIN-KINASE
    ARMBRECHT, HJ
    WONGSURAWAT, N
    ZENSER, TV
    DAVIS, BB
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (01): : E102 - E107
  • [22] Stanniocalcin 2 is positively and negatively controlled by 1,25(OH)2D3 and PTH in renal proximal tubular cells
    Takei, Yuichiro
    Yamamoto, Hironori
    Masuda, Masashi
    Sato, Tadatoshi
    Taketani, Yutaka
    Takeda, Eiji
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2009, 42 (3-4) : 261 - 268
  • [23] EFFECT OF 1,25(OH)2D3 ON ACTIVITY OF OSTEOBLASTS, OSTEOCLASTS, AND BONE REMODELING UNITS IN PATIENTS WITH RENAL OSTEODYSTROPHY
    MALLUCHE, HH
    GOLDSTEIN, DA
    MASSRY, SG
    [J]. CLINICAL RESEARCH, 1981, 29 (02): : A543 - A543
  • [24] COMPENSATORY RENAL GROWTH - MODULATION BY CALCIUM PTH AND 1,25-(OH)2D3
    JOBIN, JR
    BONJOUR, JP
    [J]. KIDNEY INTERNATIONAL, 1986, 29 (06) : 1124 - 1130
  • [25] Nutrigenomics of 1,25(OH)2D3 Action in the Intestine: Evidence for a Role of 1,25(OH)2D3 in Manganese Transport
    Li, Shanshan
    De La Cruz, Jessica
    Christakos, Sylvia
    Hur, Joseph
    Pellon-Cardenas, Oscar
    Verzi, Michael
    Shroyer, Noah
    Fleet, James
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 : 212 - 212
  • [26] EFFECT OF 1,25(OH)2D3 AND 24,25(OH)2D3 ON EXPERIMENTAL RICKETS
    KRAFT, D
    OFFERMANN, G
    STELDINGER, R
    GAWLIK, D
    [J]. RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1979, 26 (03): : 571 - 580
  • [27] 24,25(OH)2D3 ENHANCES THE CALCEMIC EFFECT OF 1,25(OH)2D3
    WALD, H
    HAYEK, T
    POPOVTZER, MM
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1985, 180 (02): : 219 - 223
  • [28] EFFECT OF PTH AND 1,25(OH)2D3 ON RENAL 25-OH-D3 METABOLISM, ADENYLATE-CYCLASE ACTIVITY, AND PROTEIN-KINASE
    ARMBRECHT, HJ
    WONGSURAWAT, N
    ZENSER, TV
    DAVIS, BB
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1983, 35 (4-5) : 689 - 689
  • [29] IS CALCITRIOL [1,25(OH)2D3] HARMFUL TO RENAL-FUNCTION
    MASSRY, SG
    GOLDSTEIN, DA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 242 (17): : 1875 - 1876
  • [30] 1,25(OH)2D3 - A NOVEL IMMUNOREGULATOR
    MANOLAGAS, SC
    TSOUKAS, CD
    PROVVEDINI, DM
    DEFTOS, LJ
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1984, 36 (04) : 519 - 519